Why We Choose the Arthrex PRP System at The Move Clinic
At The Move Clinic, we are committed to providing advanced, evidence-based treatments that give our patients the best chance of recovery and long-term results. One of the most exciting developments in regenerative medicine is the use of platelet-rich plasma (PRP) injections for joint, tendon, and soft tissue injuries.
There are many PRP systems available, but we have chosen to work with the Arthrex PRP system, a world-leading platform designed specifically for musculoskeletal medicine. Here’s why.
Higher Platelet Concentration for Better Results
Research has shown that for PRP therapy to be effective, the injected plasma should contain at least five billion platelets. These platelets release growth factors and healing signals that stimulate tissue repair, reduce inflammation, and support long-term joint health.
The Arthrex PRP system allows us to produce a plasma containing over ten billion platelets – more than double the recommended therapeutic threshold. This gives our patients the best possible chance of achieving meaningful and sustained improvements in just one injection, rather than over multiple injections.
Leucocyte-Rich or Leucocyte-Poor Options
Not all injuries are the same, and the ideal formulation of PRP depends on the target tissue.
Leucocyte-rich PRP (containing more white blood cells) may be beneficial for treating tendon injuries, where stimulating a stronger healing response is required.
Leucocyte-poor PRP is often preferred for intra-articular injections (such as osteoarthritis treatment), where reducing inflammation is important.
The Arthrex system gives us the flexibility to create both leucocyte-rich and leucocyte-poor PRP, tailoring each treatment to the individual patient and condition.
Why We Prefer PRP Over PRF
You may have heard of platelet-rich fibrin (PRF), another regenerative therapy. While PRF has gained interest in certain dental and aesthetic settings, we believe PRP is better suited for musculoskeletal conditions for several reasons:
Higher platelet concentration: PRF typically produces fewer platelets compared to PRP, often below the therapeutic threshold for joint and tendon repair.
Less flexibility: PRF is less adaptable, and it is not possible to separate leucocyte-rich from leucocyte-poor preparations in the same way as PRP.
Consistency and evidence: PRP has a stronger evidence base in musculoskeletal medicine, with more research supporting its role in osteoarthritis, tendon repair, and soft tissue healing.